ID: ALA475111

Max Phase: Preclinical

Molecular Formula: C25H37N5O4

Molecular Weight: 471.60

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCOc1ccc2c(c1)/C(=N/N1CC(=O)N(CCCCN3CCN(C)CC3)C1=O)CCO2

Standard InChI:  InChI=1S/C25H37N5O4/c1-3-4-16-33-20-7-8-23-21(18-20)22(9-17-34-23)26-30-19-24(31)29(25(30)32)11-6-5-10-28-14-12-27(2)13-15-28/h7-8,18H,3-6,9-17,19H2,1-2H3/b26-22+

Standard InChI Key:  PGTQCTFVHYAZLD-XTCLZLMSSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 471.60

Molecular Weight (Monoisotopic): 471.2846

AlogP: 2.64

#Rotatable Bonds: 10

Polar Surface Area: 77.92

Molecular Species: NEUTRAL

HBA: 7

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.95

CX Basic pKa: 8.30

CX LogP: 2.15

CX LogD: 1.20

Aromatic Rings: 1

Heavy Atoms: 34

QED Weighted: 0.39

Np Likeness Score: -0.90

References

1. Du L, Li M, Yang Q, Tang Y, You Q, Xia L..  (2009)  Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.,  19  (5): [PMID:19185489] [10.1016/j.bmcl.2009.01.022]

Source

Source(1):

• Scientific Literature